Mineralys Therapeutics (MLYS) Stock Price & Financial Analysis
Mineralys Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Mineralys Therapeutics
What is the current stock price for MLYS?
As of the latest trading session, MLYS stock trades at $25.77. The 52-week range is $12.59–$47.65, with a day range of $25.50–$26.35.
What is the P/E ratio for MLYS?
The P/E ratio (Price-to-Earnings) for MLYS is shown in the Key Statistics section. This valuation metric helps compare Mineralys Therapeutics, Inc. to industry peers.
Does MLYS pay dividends?
Mineralys Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for MLYS?
Based on 7 analysts, the consensus for MLYS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of MLYS?
Mineralys Therapeutics's market capitalization is $2.14B, classifying it as a mid-cap company. Mineralys Therapeutics operates in the Healthcare sector within the Biotechnology industry.